FGF2 and neoplasm: In vitro piroxicam appears to exert anticancer effects independently of its COX-2 inhibition, potentially by reducing tumor burden, promoting apoptosis, and in one study was found to reduce urinary concentrations of basic fibroblast growth factor (bFGF) [20].